A randomized trial finds weekly extended-release buprenorphine yields neonatal outcomes comparable to sublingual treatment.

March 22, 2026 – National Institutes of Health (NIH) released the following: ...

Weekly injectable buprenorphine is more effective than daily doses for treating opioid use disorder in pregnancy, with higher ...

In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly ...

Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more ...

More than 15 years ago, Yale's Gail D'Onofrio started studying the effectiveness of sublingual (under-the-tongue) buprenorphine for treatment of opioid use disorder (OUD) in the emergency department.

More than 15 years ago, Yale’s Gail D’Onofrio started studying the effectiveness of sublingual (under-the-tongue) buprenorphine for treatment of opioid use disorder (OUD) in the emergency department.

Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent emergency department visits or use of ...